STSA

Satsuma Pharmaceuticals, Inc. Common Stock
STSA

Overview Fund Activity
Delisted

STSA was delisted on the 7th of June, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-31
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
31
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
BCM
BML Capital Management
Indiana
-$4.5M
2
RCM
RA Capital Management
Massachusetts
-$4.13M
3
NMC
NEA Management Company
Maryland
-$1.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$643K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$289K
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
– -$5.54K -7,932 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$3.77K -5,397 Closed
UBS Group
28
UBS Group
Switzerland
– -$1.27K -1,815 Closed
Group One Trading
29
Group One Trading
Illinois
– -$311 -445 Closed
Wells Fargo
30
Wells Fargo
California
– -$130 -185 Closed
Citigroup
31
Citigroup
New York
– -$6 -8 Closed
1
2